domenica, 3 maggio 2026

Notizie Newsletter

8 Novembre 2019

Leading Cancer Organizations Collaborate to Improve the Quality of Lung Cancer Care in Brazil

November 6, 2019 - Medical oncologists in Brazil are being encouraged to take advantage of a new measure set for assessing the quality of care they provide to patients with lung cancer. Lung cancer is one of the most prevalent and deadly types of cancer in Brazil. Providing ...
Leggi tutto

8 Novembre 2019

Twenty-Four Oncology Practices Achieve ASCO’s QOPI® Certification in Third Quarter of 2019

November 7, 2019 - Twenty-Four practices in two countries elevated their standard of care and achieved Quality Oncology Practice Initiative (QOPI®) Certification in the third quarter of this year. The American Society of Clinical Oncology, Inc. (ASCO®) commends these ...
Leggi tutto

8 Novembre 2019

FDA Approves Sandoz’s Pegfilgrastim Biosimilar

November 5, 2019 - The FDA has approved the pegfilgrastim biosimilar LA-EP2006 (pegfilgrastim-bmez) as a treatment to decrease the incidence of infection, exhibited from febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer ...
Leggi tutto

4 Novembre 2019

Oncologists Call on Pennsylvania Lawmakers to Enact Legislation to Curb Payer Delays on Cancer Care

October 29, 2019 - Today the Pennsylvania Society of Oncology and Hematology (PSOH) and the American Society of Clinical Oncology (ASCO) came out in strong support of HB 1194, proposed legislation to promote transparency in prior authorization and step therapy policies, ...
Leggi tutto

4 Novembre 2019

Palliative Care Bill Unanimously Approved by U.S. House of Representatives

October 30, 2019 - On October 28, the U.S. House of Representatives unanimously approved the Palliative Care and Hospice Education and Training Act (PCHETA). The bipartisan bill would increase federal research funding for palliative care—including pain and symptom ...
Leggi tutto

4 Novembre 2019

National ASCO Survey Finds Major Gaps in Americans’ Knowledge of Cancer Prevention, E-Cigarettes, and End-of-Life Care

October 30, 2019 - Only one in four Americans say they incorporate cancer prevention into their daily lives, according to the American Society of Clinical Oncology (ASCO)’s third annual National Cancer Opinion Survey. This low rate is despite research showing that ...
Leggi tutto

4 Novembre 2019

FDA Grants RMAT Designation to CAR T-Cell Therapy CT053 for Myeloma

October 31, 2019 - The FDA has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to the investigational anti-BCMA CAR T-cell therapy CT053 for the treatment of patients with relapsed/refractory multiple myeloma. The decision was based on results from an ...
Leggi tutto

4 Novembre 2019

Avelumab/Axitinib Combo Approved in Europe for Frontline RCC

October 28, 2019 - The European Commission (EC) has approved the combination of avelumab and axitinib for the frontline treatment of adult patients with advanced renal cell carcinoma (RCC), EMD Serono (Merck KGaA) and Pfizer, the codevelopers of avelumab, reported in a press ...
Leggi tutto

4 Novembre 2019

Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice

Electronic-cigarettes (E-cigs) are marketed as a safe alternative to tobacco to deliver the stimulant nicotine, and their use is gaining in popularity, particularly among the younger population. We recently showed that mice exposed to short-term (12 wk) E-cig smoke (ECS) ...
Leggi tutto

4 Novembre 2019

Are we over-treating with checkpoint inhibitors?

Anti-PD-1 antibodies offer potentially life-saving treatment for some cancer patients, but their chronic administration generates high and ever-increasing costs. Despite licensing for long-term use, optimal treatment duration is unknown. We challenge the need for long-term ...
Leggi tutto